Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP

Elite Pharmaceuticals (ELTP) Technical Analysis

78 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Elite Pharmaceuticals’s (ELTP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Elite Pharmaceuticals is a Buy.
Elite Pharmaceuticals’s (ELTP) 20-Day exponential moving average is 0.08, while Elite Pharmaceuticals’s (ELTP) share price is <$0.1, making it a Buy.
Elite Pharmaceuticals’s (ELTP) 50-Day exponential moving average is 0.07, while Elite Pharmaceuticals’s (ELTP) share price is <$0.1, making it a Buy.

Elite Pharmaceuticals (ELTP) Pivot Points

Sep 29, 2023, 03:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.08
0.09
0.09
0.09
0.10
0.10
Fibonacci
0.08
0.09
0.09
0.09
0.09
0.09
0.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elite Pharmaceuticals (ELTP) Moving Averages

Sep 29, 2023, 03:35 PM
Period
Simple
Exponential
MA5
0.09Sell
0.09Buy
MA10
0.08Buy
0.09Buy
MA20
0.08Buy
0.08Buy
MA50
0.07Buy
0.07Buy
MA100
0.05Buy
0.06Buy
MA200
0.04Buy
0.05Buy
Elite Pharmaceuticals’s (ELTP) 10-Day exponential moving average is 0.09, while Elite Pharmaceuticals’s (ELTP) share price is <$0.1, making it a Buy.
Elite Pharmaceuticals’s (ELTP) 100-Day exponential moving average is 0.06, while Elite Pharmaceuticals’s (ELTP) share price is <$0.1, making it a Buy.
Elite Pharmaceuticals’s (ELTP) stock price is <$0.1 and Elite Pharmaceuticals’s (ELTP) 50-day simple moving average is 0.07, creating a Buy signal.
Elite Pharmaceuticals’s (ELTP) stock price is <$0.1 and Elite Pharmaceuticals’s (ELTP) 100-day simple moving average is 0.05, creating a Buy signal.
Elite Pharmaceuticals’s (ELTP) stock price is <$0.1 and Elite Pharmaceuticals’s (ELTP) 200-day simple moving average is 0.04, creating a Buy signal.

Elite Pharmaceuticals (ELTP) Technical Indicators

Sep 29, 2023, 03:35 PM
Name
Value
Implied Action
RSI (14)
64.19
Neutral
STOCH (9,6)
77.19
Neutral
STOCHRSI (14)
87.98
Sell
MACD (12,26)
<0.01
Buy
ADX (14)
21.13
Neutral
Williams %R
-15.00
Sell
CCI (14)
102.40
Sell
ATR (14)
0.01
-
Ultimate Oscillator
57.45
Neutral
ROC
12.50
Buy
Elite Pharmaceuticals’s (ELTP) Relative Strength Index (RSI) is 64.19, creating a Neutral signal.
Elite Pharmaceuticals’s (ELTP) Trend Strength Indicator (ADX) is 21.13, creating a Neutral signal.
Elite Pharmaceuticals’s (ELTP) Commodity Channel Index (CCI) is 102.40, creating a Sell signal.
Elite Pharmaceuticals’s (ELTP) Price Rate of Change (ROC) is 12.50, creating a Buy signal.

FAQ

Is ELTP a Buy, Hold, or Sell?
Based on ELTP’s technical indicators, ELTP is a Buy.
    What is ELTP’s RSI (14)?
    ELTP’s RSI (14) is 64.19, which suggests ELTP is a Neutral.
      What is ELTP’s MACD?
      ELTP’s MACD is <0.01, which suggests ELTP is a Buy.
        What is ELTP’s 5-day moving average?
        ELTP’s 5-day moving average is 0.09, which suggests ELTP is a Sell.
          What is ELTP’s 20-day moving average?
          ELTP 20-day moving average is 0.08, which suggests ELTP is a Buy.
            What is ELTP’s 50-day moving average?
            ELTP’s 50-day moving average is 0.07, which suggests ELTP is a Buy.
              What is ELTP’s 200-day moving average?
              ELTP’s 200-day moving average is 0.04, which suggests ELTP is a Buy.
                What is ELTP’s Williams % R (14)?
                ELTP’s Williams % R (14) is -15.00, which suggests ELTP is a Sell.
                  What is ELTP’s CCI (14)?
                  ELTP’s CCI (14) is 102.40, which suggests ELTP is a Sell.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis